You are here: HomePubsPub-2018BTK Cys481Ser drives ibrutinib resistance via ERK1/2, and protects BTK Wild-Type MYD88 mutated cells by a paracrine mechanism
BTK Cys481Ser drives ibrutinib resistance via ERK1/2, and protects BTK Wild-Type MYD88 mutated cells by a paracrine mechanism